We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XMPT icon
3176
VanEck CEF Muni Income ETF
XMPT
$220M
$216K ﹤0.01%
8,017
EQH icon
3177
Equitable Holdings
EQH
$14.1B
$215K ﹤0.01%
+10,289
New +$221K
GLDD
3178
DELISTED
Great Lakes Dredge & Dock
GLDD
$215K ﹤0.01%
19,467
-2,370
-11% -$24.5K
GMS
3179
DELISTED
GMS Inc
GMS
$215K ﹤0.01%
+9,767
New +$175K
BDSI
3180
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$215K ﹤0.01%
46,211
EMDV icon
3181
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.39M
$214K ﹤0.01%
3,660
MLP icon
3182
Maui Land & Pineapple Co
MLP
$344M
$214K ﹤0.01%
20,845
JRS icon
3183
Nuveen Real Estate Income Fund
JRS
$246M
$213K ﹤0.01%
20,299
-1,137
-5% -$11.7K
CXW icon
3184
CoreCivic
CXW
$3.19B
$212K ﹤0.01%
10,231
-89,313
-90% -$1.92M
MLPX icon
3185
Global X MLP & Energy Infrastructure ETF
MLPX
$3.5B
$212K ﹤0.01%
5,464
+543
+11% +$21.1K
DBA icon
3186
Invesco DB Agriculture Fund
DBA
$1.23B
$211K ﹤0.01%
12,739
-369
-3% -$6.07K
EGHT icon
3187
8x8 Inc
EGHT
$332M
$211K ﹤0.01%
+8,735
New +$203K
PATI
3188
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$211K ﹤0.01%
12,428
+900
+8% +$16.7K
CEO
3189
DELISTED
CNOOC Limited
CEO
$211K ﹤0.01%
1,240
-2,470
-67% -$430K
EVG
3190
Eaton Vance Short Duration Diversified Income Fund
EVG
$143M
$210K ﹤0.01%
15,496
+20
+0.1% +$262
RWT
3191
Redwood Trust
RWT
$594M
$210K ﹤0.01%
12,724
+1,100
+9% +$17.8K
SM icon
3192
SM Energy
SM
$6.87B
$210K ﹤0.01%
16,762
-6,000
-26% -$87.1K
MRTX
3193
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$210K ﹤0.01%
+2,043
New +$159K
VRAY
3194
DELISTED
ViewRay, Inc.
VRAY
$210K ﹤0.01%
23,800
+5,400
+29% +$43.8K
HEXO
3195
DELISTED
HEXO Corp. Common Shares
HEXO
$210K ﹤0.01%
704
+490
+229% +$181K
CCI.PRA
3196
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$210K ﹤0.01%
175
ETN icon
3197
CALL
Eaton
ETN
$174B
$209K ﹤0.01%
161,000
-7,100
-4% -$575K
IMO icon
3198
Imperial Oil
IMO
$60.4B
$209K ﹤0.01%
7,570
-4,397
-37% -$123K
SRPT icon
3199
PUT
Sarepta Therapeutics
SRPT
$1.77B
$209K ﹤0.01%
+23,500
New +$2.86M
HTLF
3200
DELISTED
Heartland Financial USA, Inc.
HTLF
$209K ﹤0.01%
+4,661
New +$206K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.